About: The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type. Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Older patients with AML have poor prognosis after chemotherapy and allo-SCT was historically limited to the young patients. Our analysis indicates that outcomes of allografted AML patients older than 50 years are determined by cytogenetic risk category and disease status at transplantation and not by the type of donor. Older patients with AML have poor prognosis after chemotherapy and allo-SCT was historically limited to the young patients. Our analysis indicates that outcomes of allografted AML patients older than 50 years are determined by cytogenetic risk category and disease status at transplantation and not by the type of donor. (en)
Title	The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type. The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type. (en)
skos:prefLabel	The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type. The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type. (en)
skos:notation	RIV/00098892:_____/13:#0000568!RIV14-MZ0-00098892
http://linked.open...avai/riv/aktivita	P
http://linked.open...avai/riv/aktivity	P(NT12454)
http://linked.open...iv/cisloPeriodika	5
http://linked.open...vai/riv/dodaniDat	2014
http://linked.open...aciTvurceVysledku	Raida, Luděk INDRÁK, Karel
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Fakultní nemocnice Olomouc
http://linked.open...dnocenehoVysledku	94886
http://linked.open...ai/riv/idVysledku	RIV/00098892:_____/13:#0000568
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	AML, allogeneic HSCT, age, donor (en)
http://linked.open.../riv/klicoveSlovo	allogeneic HSCT AML age donor
http://linked.open...odStatuVydavatele	SK - Slovenská republika
http://linked.open...ontrolniKodProRIV	[CFC009D51405]
http://linked.open...i/riv/nazevZdroje	Neoplasma
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	2 (xsd:int)
http://linked.open...cetTvurcuVysledku	11 (xsd:int)
http://linked.open...vavai/riv/projekt	Selected immunological and immunogenetic parameters in the prediction of graft versus host disease and the outcome of allogeneic haematopoietic stem cell transplantation
http://linked.open...UplatneniVysledku	2013
http://linked.open...v/svazekPeriodika	60
http://linked.open...iv/tvurceVysledku	Indrák, Karel Raida, Luděk
issn	0028-2685
number of pages	8 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software